{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:37:08Z","timestamp":1791020228300,"version":"4.1.0"},"reference-count":118,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Biopsy is a pivotal component in the diagnostic process of bone and soft tissue tumors. The objective is to obtain adequate tissue without compromising local tumor dissemination and the patient\u2019s survival. This review explores contemporary principles and practices in musculoskeletal biopsies, emphasizing the critical role of diagnostic accuracy while also delving into the evolving landscape of liquid biopsies as a promising alternative in the field. A thorough literature search was done in PubMed and Google Scholar as well as in physical books in libraries to summarize the available biopsy techniques for musculoskeletal tumors, discuss the available methods, risk factors, and complications, and to emphasize the challenges related to biopsies in oncology. Research articles that studied the basic principles and specialized techniques of biopsy techniques in tumor patients were deemed eligible. Their advantages and disadvantages, technical and pathophysiological mechanisms, and possible risks and complications were reviewed, summarized, and discussed. An inadequately executed biopsy may hinder diagnosis and subsequently impact treatment outcomes. All lesions should be approached with a presumption of malignancy until proven otherwise. Liquid biopsies have emerged as a potent non-invasive tool for analyzing tumor phenotype, progression, and drug resistance and guiding treatment decisions in bone sarcomas and metastases. Despite advancements, several barriers remain in biopsies, including challenges related to costs, scalability, reproducibility, and isolation methods. It is paramount that orthopedic oncologists work together with radiologists and pathologists to enhance diagnosis, patient outcomes, and healthcare costs.<\/jats:p>","DOI":"10.3390\/curroncol31020067","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T08:28:16Z","timestamp":1707294496000},"page":"900-917","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Biopsy Techniques for Musculoskeletal Tumors: Basic Principles and Specialized Techniques"],"prefix":"10.3390","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0807-0719","authenticated-orcid":false,"given":"Andreas","family":"Mavrogenis","sequence":"first","affiliation":[{"name":"First Department of Orthopaedics, School of Medicine, National and Kapodistrian University of Athens, 1 Rimini, 157 72 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlos","family":"Altsitzioglou","sequence":"additional","affiliation":[{"name":"First Department of Orthopaedics, School of Medicine, National and Kapodistrian University of Athens, 1 Rimini, 157 72 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8419-2008","authenticated-orcid":false,"given":"Shinji","family":"Tsukamoto","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4504-2867","authenticated-orcid":false,"given":"Costantino","family":"Errani","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Oncology, IRCCS Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1007\/s11999-010-1401-x","article-title":"A Comparison of Fine-Needle Aspiration, Core Biopsy, and Surgical Biopsy in the Diagnosis of Extremity Soft Tissue Masses","volume":"468","author":"Kasraeian","year":"2010","journal-title":"Clin. Orthop. Relat. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00003086-199911000-00026","article-title":"Biopsy of Musculoskeletal Tumors. Current Concepts","volume":"368","author":"Bickels","year":"1999","journal-title":"Clin. Orthop. Relat. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00003086-199603000-00011","article-title":"Long-Term Results of Allograft Replacement in the Management of Bone Tumors","volume":"324","author":"Mankin","year":"1996","journal-title":"Clin. Orthop. Relat. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0030-1253517","article-title":"Image-Guided Musculoskeletal Biopsies","volume":"27","author":"Le","year":"2010","journal-title":"Semin. Intervent. Radiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/2047-783X-17-29","article-title":"Percutaneous Core Needle Biopsy versus Open Biopsy in Diagnostics of Bone and Soft Tissue Sarcoma: A Retrospective Study","volume":"17","author":"Pohlig","year":"2012","journal-title":"Eur. J. Med. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1007\/s11999-010-1422-5","article-title":"Office-Based Core Needle Biopsy of Bone and Soft Tissue Malignancies: An Accurate Alternative to Open Biopsy with Infrequent Complications","volume":"468","author":"Adams","year":"2010","journal-title":"Clin. Orthop. Relat. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"759","DOI":"10.5858\/2004-128-759-CONCBA","article-title":"Comparison of Needle Core Biopsy and Fine-Needle Aspiration for Diagnostic Accuracy in Musculoskeletal Lesions","volume":"128","author":"Yang","year":"2004","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1445-2197.1998.tb04769.x","article-title":"Pre-Operative Core Biopsy of Soft-Tissue Tumours Facilitates Their Surgical Management","volume":"68","author":"Serpell","year":"1998","journal-title":"Aust. N. Z. J. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1600-0463.2005.apm_113507.x","article-title":"Usefulness and Limitations of Ultrasound-Guided Core Biopsy in the Diagnosis of Musculoskeletal Tumours","volume":"113","author":"Zabala","year":"2005","journal-title":"APMIS"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2106\/00004623-199605000-00002","article-title":"Diagnostic Accuracy and Charge-Savings of Outpatient Core Needle Biopsy Compared with Open Biopsy of Musculoskeletal Tumors","volume":"78","author":"Skrzynski","year":"1996","journal-title":"J. Bone Joint Surg. Am."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00586-008-0678-x","article-title":"Percutaneous CT-Guided Biopsy of the Spine: Results of 430 Biopsies","volume":"17","author":"Rimondi","year":"2008","journal-title":"Eur. Spine J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/jcu.20038","article-title":"Sonographically Guided Core Needle Biopsy of Soft Tissue Neoplasms","volume":"32","author":"Liu","year":"2004","journal-title":"J. Clin. Ultrasound"},{"key":"ref_13","first-page":"277","article-title":"The Diagnosis of Soft Tissue Tumours","volume":"74","author":"Serpell","year":"1992","journal-title":"Ann. R. Coll. Surg. Engl."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00266974","article-title":"Preoperative Diagnosis of Soft Tissue Tumours","volume":"12","author":"Rydholm","year":"1988","journal-title":"Int. Orthop."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/BF02305557","article-title":"Core Needle Biopsy for Diagnosis of Extremity Soft Tissue Sarcoma","volume":"4","author":"Heslin","year":"1997","journal-title":"Ann. Surg. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2106\/00004623-197759020-00014","article-title":"The Effect of Biopsy-Hole Shape and Size on Bone Strength","volume":"59","author":"Clark","year":"1977","journal-title":"J. Bone Joint Surg Am."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00264-009-0835-9","article-title":"The Diagnostic Value of Needle Biopsy for Musculoskeletal Lesions","volume":"33","author":"Sung","year":"2009","journal-title":"Int. Orthop."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00256-012-1542-y","article-title":"The Role of Needle Biopsy for Focal Bone Lesions with Complete Fluid-Fluid Levels on Magnetic Resonance Imaging","volume":"42","author":"Rajeswaran","year":"2013","journal-title":"Skelet. Radiol."},{"key":"ref_19","first-page":"236","article-title":"Soft-Tissue Tumors-Role of Diagnostic Imaging","volume":"106","author":"Lehotska","year":"2005","journal-title":"Bratisl. Lek. Listy."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1007\/s11999-009-0965-9","article-title":"Biopsy of Soft Tissue Masses: Evidence-Based Medicine for the Musculoskeletal Tumor Society","volume":"467","author":"Rougraff","year":"2009","journal-title":"Clin. Orthop. Relat. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s007760050074","article-title":"Diagnosis and Treatment of Soft Tissue Tumors","volume":"4","author":"Iwamoto","year":"1999","journal-title":"J. Orthop. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12306-012-0225-0","article-title":"Pleomorphic Spindle Cell Sarcoma (PSCS) Formerly Known as Malignant Fibrous Histiocytoma (MFH): A Complex Malignant Soft-Tissue Tumor","volume":"96","author":"Mankin","year":"2012","journal-title":"Musculoskelet. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12306-013-0247-2","article-title":"The Portrayal of Bone Tumours in the Press","volume":"97","author":"Danesh","year":"2013","journal-title":"Musculoskelet. Surg."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s11999-009-1100-7","article-title":"Fine Needle Aspiration for Clinical Triage of Extremity Soft Tissue Masses","volume":"468","author":"Ng","year":"2010","journal-title":"Clin. Orthop. Relat. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3389\/fonc.2020.01055","article-title":"The Metastatic Cascade as the Basis for Liquid Biopsy Development","volume":"10","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1758835918794630","DOI":"10.1177\/1758835918794630","article-title":"Liquid Biopsy of Cancer: A Multimodal Diagnostic Tool in Clinical Oncology","volume":"10","author":"Palmirotta","year":"2018","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.canlet.2018.09.012","article-title":"Application of Liquid Biopsy in Bone and Soft Tissue Sarcomas: Present and Future","volume":"439","author":"Li","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Perakis, S., and Speicher, M.R. (2017). Emerging Concepts in Liquid Biopsies. BMC Med., 15.","DOI":"10.1186\/s12916-017-0840-6"},{"key":"ref_29","first-page":"819362","article-title":"Detection of Circulating Tumor Cells","volume":"2014","author":"Terstappen","year":"2014","journal-title":"Scientifica"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12935-019-1067-8","article-title":"Circulating Tumor Cells in Precision Oncology: Clinical Applications in Liquid Biopsy and 3D Organoid Model","volume":"19","author":"Yang","year":"2019","journal-title":"Cancer Cell Int."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Mauri, G., Bonazzina, E., Amatu, A., Tosi, F., Bencardino, K., Gori, V., Massihnia, D., Cipani, T., Spina, F., and Ghezzi, S. (2021). The Evolutionary Landscape of Treatment for BRAFV600E Mutant Metastatic Colorectal Cancer. Cancers, 13.","DOI":"10.3390\/cancers13010137"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1479-5876-10-85","article-title":"The Role of BRAF V600 Mutation in Melanoma","volume":"10","author":"Ascierto","year":"2012","journal-title":"J. Transl. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jmoldx.2017.10.002","article-title":"Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype: Findings from Molecular and Immunohistochemical Analysis","volume":"20","author":"Pellegrini","year":"2018","journal-title":"J. Mol. Diagn."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3892\/mco.2021.2478","article-title":"Variations in MAP Kinase Gladiators and Risk of Differentiated Thyroid Carcinoma","volume":"16","author":"Rashid","year":"2022","journal-title":"Mol. Clin. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrclinonc.2013.110","article-title":"Liquid Biopsy: Monitoring Cancer-Genetics in the Blood","volume":"10","author":"Crowley","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","article-title":"Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles","volume":"30","author":"Colombo","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Doyle, L.M., and Wang, M.Z. (2019). Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis. Cells, 8.","DOI":"10.3390\/cells8070727"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Stevic, I., Buescher, G., and Ricklefs, F.L. (2020). Monitoring Therapy Efficiency in Cancer through Extracellular Vesicles. Cells, 9.","DOI":"10.3390\/cells9010130"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Green, T.M., Alpaugh, M.L., Barsky, S.H., Rappa, G., and Lorico, A. (2015). Breast Cancer-Derived Extracellular Vesicles: Characterization and Contribution to the Metastatic Phenotype. Biomed. Res. Int., 2015.","DOI":"10.1155\/2015\/634865"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Taverna, S., Giusti, I., D\u2019Ascenzo, S., Pizzorno, L., and Dolo, V. (2020). Breast Cancer Derived Extracellular Vesicles in Bone Metastasis Induction and Their Clinical Implications as Biomarkers. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103573"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Ludwig, N., Whiteside, T.L., and Reichert, T.E. (2019). Challenges in Exosome Isolation and Analysis in Health and Disease. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20194684"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e1413","DOI":"10.1002\/wrna.1413","article-title":"RNA in Extracellular Vesicles","volume":"8","author":"Kim","year":"2017","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrclinonc.2017.14","article-title":"Integrating Liquid Biopsies into the Management of Cancer","volume":"14","author":"Siravegna","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Russo, A., Giordano, A., and Rolfo, C. (2017). Liquid Biopsy in Cancer Patients: The Hand Lens for Tumor Evolution, Springer International Publishing. Current Clinical Pathology.","DOI":"10.1007\/978-3-319-55661-1"},{"key":"ref_45","first-page":"302ra133","article-title":"Mutation Tracking in Circulating Tumor DNA Predicts Relapse in Early Breast Cancer","volume":"7","author":"Schiavon","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1158\/1078-0432.CCR-13-2933","article-title":"Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer","volume":"20","author":"Beaver","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"P\u00e9cuchet, N., Zonta, E., Didelot, A., Combe, P., Thibault, C., Gibault, L., Lours, C., Rozenholc, Y., Taly, V., and Laurent-Puig, P. (2016). Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study. PLoS Med., 13.","DOI":"10.1371\/journal.pmed.1002199"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/1724600817753576","article-title":"Circulating Tumor DNA as Prognostic Markers for Late Stage NSCLC with Bone Metastasis","volume":"33","author":"Jia","year":"2018","journal-title":"Int. J. Biol. Markers"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.eururo.2018.12.042","article-title":"Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer","volume":"75","author":"Vandekerkhove","year":"2019","journal-title":"Eur. Urol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1470-2045(14)70069-5","article-title":"Clinical Validity of Circulating Tumour Cells in Patients with Metastatic Breast Cancer: A Pooled Analysis of Individual Patient Data","volume":"15","author":"Bidard","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"85","DOI":"10.17294\/2330-0698.1017","article-title":"Circulating Tumor Cells in Metastatic Breast Cancer: A Prognostic and Predictive Marker","volume":"1","author":"Wisinski","year":"2014","journal-title":"J. Patient Cent. Res. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/annonc\/mdp262","article-title":"Circulating Tumor Cells and Bone Metastases as Detected by FDG-PET\/CT in Patients with Metastatic Breast Cancer","volume":"21","author":"Valero","year":"2010","journal-title":"Ann. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nbt.2576","article-title":"Identification of a Population of Blood Circulating Tumor Cells from Breast Cancer Patients That Initiates Metastasis in a Xenograft Assay","volume":"31","author":"Baccelli","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"6369","DOI":"10.7314\/APJCP.2014.15.15.6369","article-title":"Circulating Tumor Cells Are Associated with Bone Metastasis of Lung Cancer","volume":"15","author":"Cheng","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1200\/JCO.2010.28.7045","article-title":"Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients with Non-Small-Cell Lung Cancer","volume":"29","author":"Krebs","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1158\/1078-0432.CCR-06-2701","article-title":"Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer","volume":"13","author":"Shaffer","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1158\/1078-0432.CCR-08-0872","article-title":"Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer","volume":"14","author":"Scher","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1373\/clinchem.2008.117952","article-title":"Circulating Prostate Tumor Cells Detected by Reverse Transcription-PCR in Men with Localized or Castration-Refractory Prostate Cancer: Concordance with CellSearch Assay and Association with Bone Metastases and with Survival","volume":"55","author":"Helo","year":"2009","journal-title":"Clin. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41523-021-00319-4","article-title":"Multimodal Liquid Biopsy for Early Monitoring and Outcome Prediction of Chemotherapy in Metastatic Breast Cancer","volume":"7","author":"Bidard","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/1878-0261.12305","article-title":"Correlation between Circulating Cell-Free PIK3CA Tumor DNA Levels and Treatment Response in Patients with PIK3CA-Mutated Metastatic Breast Cancer","volume":"12","author":"Kodahl","year":"2018","journal-title":"Mol. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa1213261","article-title":"Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer","volume":"368","author":"Dawson","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1158\/1078-0432.CCR-15-1534","article-title":"Sensitive Detection of Mono-and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients","volume":"22","author":"Wang","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1158\/1078-0432.CCR-17-2092","article-title":"Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer","volume":"24","author":"Rossi","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"100374","DOI":"10.1016\/j.jbo.2021.100374","article-title":"A Predictive Biomarker Panel for Bone Metastases: Liquid Biopsy Approach","volume":"29","author":"Bhadresha","year":"2021","journal-title":"J. Bone Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10585-020-10062-y","article-title":"Correlation of Exosomal microRNA Clusters with Bone Metastasis in Non-Small Cell Lung Cancer","volume":"38","author":"Yang","year":"2021","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/bjc.2011.595","article-title":"Changes in Circulating microRNA Levels Associated with Prostate Cancer","volume":"106","author":"Bryant","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.18632\/oncotarget.6983","article-title":"Prostate Extracellular Vesicles in Patient Plasma as a Liquid Biopsy Platform for Prostate Cancer Using Nanoscale Flow Cytometry","volume":"7","author":"Biggs","year":"2016","journal-title":"Oncotarget"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.eururo.2018.08.019","article-title":"A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-Grade Prostate Cancer in Patients with Prostate-Specific Antigen 2-10ng\/Ml at Initial Biopsy","volume":"74","author":"McKiernan","year":"2018","journal-title":"Eur. Urol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"12695","DOI":"10.18632\/oncotarget.24268","article-title":"Detection of Circulating Tumor DNA in Patients with Osteosarcoma","volume":"9","author":"Barris","year":"2018","journal-title":"Oncotarget"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41416-018-0212-9","article-title":"Detection of Circulating Tumour DNA Is Associated with Inferior Outcomes in Ewing Sarcoma and Osteosarcoma: A Report from the Children\u2019s Oncology Group","volume":"119","author":"Shulman","year":"2018","journal-title":"Br. J. Cancer"},{"key":"ref_71","first-page":"1","article-title":"Plasma DNA-Based Molecular Diagnosis, Prognostication, and Monitoring of Patients with EWSR1 Fusion-Positive Sarcomas","volume":"1","author":"Shukla","year":"2017","journal-title":"JCO Precis. Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1002\/cncr.30144","article-title":"Highly Personalized Detection of Minimal Ewing Sarcoma Disease Burden from Plasma Tumor DNA","volume":"122","author":"Hayashi","year":"2016","journal-title":"Cancer"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3892\/ijo.2017.3905","article-title":"A Liquid Biopsy-Based Method for the Detection and Quantification of Circulating Tumor Cells in Surgical Osteosarcoma Patients","volume":"50","author":"Zhang","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"100236","DOI":"10.1016\/j.jbo.2019.100236","article-title":"Prognostic and Clinicopathological Significance of Circulating Tumor Cells in Osteosarcoma","volume":"16","author":"Li","year":"2019","journal-title":"J. Bone Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.2147\/CMAR.S176515","article-title":"Significance of Circulating Tumor Cells in Osteosarcoma Patients Treated by Neoadjuvant Chemotherapy and Surgery","volume":"10","author":"Wu","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jbo.2018.07.002","article-title":"Isolation of Circulating Tumor Cells in a Preclinical Model of Osteosarcoma: Effect of Chemotherapy","volume":"12","author":"Chalopin","year":"2018","journal-title":"J. Bone Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/CMAR.S141623","article-title":"Detection of Circulating Tumor Cells in Liquid Biopsy from Ewing Sarcoma Patients","volume":"10","author":"Benini","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1200\/JCO.2003.03.006","article-title":"Increased Risk of Systemic Relapses Associated with Bone Marrow Micrometastasis and Circulating Tumor Cells in Localized Ewing Tumor","volume":"21","author":"Schleiermacher","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"78965","DOI":"10.18632\/oncotarget.20697","article-title":"Size-Based Detection of Sarcoma Circulating Tumor Cells and Cell Clusters","volume":"8","author":"Hayashi","year":"2017","journal-title":"Oncotarget"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1245\/s10434-018-6642-z","article-title":"Extracellular Vesicle RNA Sequencing Reveals Dramatic Transcriptomic Alterations Between Metastatic and Primary Osteosarcoma in a Liquid Biopsy Approach","volume":"25","author":"Bao","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"12467","DOI":"10.1007\/s13277-014-2565-x","article-title":"Circulating miR-148a Is a Significant Diagnostic and Prognostic Biomarker for Patients with Osteosarcoma","volume":"35","author":"Ma","year":"2014","journal-title":"Tumor Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3233\/CBM-150493","article-title":"Increased Expression of microRNA-191 as a Potential Serum Biomarker for Diagnosis and Prognosis in Human Osteosarcoma","volume":"15","author":"Wang","year":"2015","journal-title":"Cancer Biomark."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"9001","DOI":"10.1007\/s13277-015-4578-5","article-title":"miR-421 Is a Diagnostic and Prognostic Marker in Patients with Osteosarcoma","volume":"37","author":"Zhou","year":"2016","journal-title":"Tumor Biol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3233\/CBM-170672","article-title":"Identification of Serum miR-124 as a Biomarker for Diagnosis and Prognosis in Osteosarcoma","volume":"21","author":"Cong","year":"2018","journal-title":"Cancer Biomark."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/CBM-171103","article-title":"Diagnostic and Prognostic Implications of Serum miR-101 in Osteosarcoma","volume":"22","author":"Yao","year":"2018","journal-title":"Cancer Biomark."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jss.2014.11.025","article-title":"Serum miR-195 Is a Diagnostic and Prognostic Marker for Osteosarcoma","volume":"194","author":"Cai","year":"2015","journal-title":"J. Surg. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"19049","DOI":"10.4238\/2015.December.29.12","article-title":"Circulating miR-125b as a Biomarker of Ewing\u2019s Sarcoma in Chinese Children","volume":"14","author":"Nie","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.18632\/oncotarget.27678","article-title":"Ewing Sarcoma Family of Tumors-Derived Small Extracellular Vesicle Proteomics Identify Potential Clinical Biomarkers","volume":"11","author":"Samuel","year":"2020","journal-title":"Oncotarget"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13046-020-01601-2","article-title":"Liquid Biopsy and Tumor Heterogeneity in Metastatic Solid Tumors: The Potentiality of Blood Samples","volume":"39","author":"Russano","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"313ra182","DOI":"10.1126\/scitranslmed.aac7551","article-title":"Analysis of ESR1 Mutation in Circulating Tumor DNA Demonstrates Evolution during Therapy for Metastatic Breast Cancer","volume":"7","author":"Schiavon","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/s41467-018-03215-x","article-title":"Early Circulating Tumor DNA Dynamics and Clonal Selection with Palbociclib and Fulvestrant for Breast Cancer","volume":"9","author":"Hrebien","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1158\/2159-8290.CD-18-0264","article-title":"The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial","volume":"8","author":"Cutts","year":"2018","journal-title":"Cancer Discov."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1200\/JCO.2016.67.3061","article-title":"Plasma ESR1 Mutations and the Treatment of Estrogen Receptor-Positive Advanced Breast Cancer","volume":"34","author":"Fribbens","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13058-021-01415-w","article-title":"Circulating Tumor Cells and Palbociclib Treatment in Patients with ER-Positive, HER2-Negative Advanced Breast Cancer: Results from a Translational Sub-Study of the TREnd Trial","volume":"23","author":"Galardi","year":"2021","journal-title":"Breast Cancer Res."},{"key":"ref_96","first-page":"6705","article-title":"Circulating Tumor Cells as a Biomarker Predictive of Sensitivity to Docetaxel Chemotherapy in Patients with Castration-Resistant Prostate Cancer","volume":"34","author":"Okegawa","year":"2014","journal-title":"Anticancer Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1177\/0300060517734114","article-title":"MicroRNA-375 as a Potential Serum Biomarker for the Diagnosis, Prognosis, and Chemosensitivity Prediction of Osteosarcoma","volume":"46","author":"Liu","year":"2018","journal-title":"J. Int. Med. Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/j.ymthe.2017.05.018","article-title":"miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting \u03b1B-Crystallin","volume":"25","author":"Wang","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1177\/030006051204000606","article-title":"Identification of Serum microRNA-21 as a Biomarker for Chemosensitivity and Prognosis in Human Osteosarcoma","volume":"40","author":"Yuan","year":"2012","journal-title":"J. Int. Med. Res."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Xavier, C.P.R., Caires, H.R., Barbosa, M.A.G., Bergantim, R., Guimar\u00e3es, J.E., and Vasconcelos, M.H. (2020). The Role of Extracellular Vesicles in the Hallmarks of Cancer and Drug Resistance. Cells, 9.","DOI":"10.3390\/cells9051141"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3892\/ijo.2016.3509","article-title":"Multimodal Transfer of MDR by Exosomes in Human Osteosarcoma","volume":"49","author":"Torreggiani","year":"2016","journal-title":"Int. J. Oncol."},{"key":"ref_102","first-page":"165","article-title":"Clinical and Functional Significance of Intracellular and Extracellular microRNA-25-3p in Osteosarcoma","volume":"72","author":"Yoshida","year":"2018","journal-title":"Acta Med. Okayama"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12943-017-0694-8","article-title":"Exosomes Derived from Gemcitabine-Resistant Cells Transfer Malignant Phenotypic Traits via Delivery of miRNA-222-3p","volume":"16","author":"Wei","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1158\/1055-9965.EPI-18-0569","article-title":"Prognostic Role of Circulating Exosomal miR-425-3p for the Response of NSCLC to Platinum-Based Chemotherapy","volume":"28","author":"Yuwen","year":"2019","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"10415","DOI":"10.18632\/aging.202802","article-title":"Exosomal miR-222 from Adriamycin-Resistant MCF-7 Breast Cancer Cells Promote Macrophages M2 Polarization via PTEN\/Akt to Induce Tumor Progression","volume":"13","author":"Chen","year":"2021","journal-title":"Aging"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Kreger, B.T., Johansen, E.R., Cerione, R.A., and Antonyak, M.A. (2016). The Enrichment of Survivin in Exosomes from Breast Cancer Cells Treated with Paclitaxel Promotes Cell Survival and Chemoresistance. Cancers, 8.","DOI":"10.3390\/cancers8120111"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/jcp.22773","article-title":"Potential Role of HER2-Overexpressing Exosomes in Countering Trastuzumab-Based Therapy","volume":"227","author":"Ciravolo","year":"2012","journal-title":"J. Cell Physiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.gene.2017.04.031","article-title":"Predictive Role of GSTP1-Containing Exosomes in Chemotherapy-Resistant Breast Cancer","volume":"623","author":"Yang","year":"2017","journal-title":"Gene"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/cas.13150","article-title":"Increasing Circulating Exosomes-Carrying TRPC5 Predicts Chemoresistance in Metastatic Breast Cancer Patients","volume":"108","author":"Wang","year":"2017","journal-title":"Cancer Sci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"21740","DOI":"10.18632\/oncotarget.3226","article-title":"Molecular Profiling of Prostate Cancer Derived Exosomes May Reveal a Predictive Signature for Response to Docetaxel","volume":"6","author":"Kharaziha","year":"2015","journal-title":"Oncotarget"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/clinchem\/hvaa103","article-title":"Plasma or Serum: Which Is Preferable for Mutation Detection in Liquid Biopsy?","volume":"66","author":"Chin","year":"2020","journal-title":"Clin. Chem."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2017.76.8671","article-title":"Circulating Tumor DNA Analysis in Patients with Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review","volume":"36","author":"Merker","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/s41467-017-01705-y","article-title":"Whole Blood Stabilization for the Microfluidic Isolation and Molecular Characterization of Circulating Tumor Cells","volume":"8","author":"Wong","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/cyto.a.23669","article-title":"Diagnostic Leukapheresis for CTC Analysis in Breast Cancer Patients: CTC Frequency, Clinical Experiences and Recommendations for Standardized Reporting","volume":"93","author":"Fehm","year":"2018","journal-title":"Cytom. Part A"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.ebiom.2015.09.019","article-title":"Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells","volume":"2","author":"Terai","year":"2015","journal-title":"EBioMedicine"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/1878-0261.12534","article-title":"Tumor-Proximal Liquid Biopsy to Improve Diagnostic and Prognostic Performances of Circulating Tumor Cells","volume":"13","author":"Buscail","year":"2019","journal-title":"Mol. Oncol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/ijc.33217","article-title":"Liquid Biopsies: Potential and Challenges","volume":"148","author":"Heidrich","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/s41598-020-57497-7","article-title":"A Comparison of Methods for the Isolation and Separation of Extracellular Vesicles from Protein and Lipid Particles in Human Serum","volume":"10","author":"Brennan","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/31\/2\/67\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:55:03Z","timestamp":1760104503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/31\/2\/67"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,5]]},"references-count":118,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["curroncol31020067"],"URL":"https:\/\/doi.org\/10.3390\/curroncol31020067","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,5]]}}}